B.Riley/FBR Downgrades Adamis Pharmaceuticals (ADMP) to Sell
Tweet
Share
E-mailGet Alerts ADMP Hot Sheet
Price: $0.78 --0%
Rating Summary:
3 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
3 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
B.Riley/FBR analyst Andrew D\'Silva downgraded Adamis Pharmaceuticals (NASDAQ: ADMP) from Neutral to Sell with a price target of $1.10 (from $1.90).
For an analyst ratings summary and ratings history on Adamis Pharmaceuticals click here. For more ratings news on Adamis Pharmaceuticals click here.
Shares of Adamis Pharmaceuticals closed at $1.46 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Grocery Outlet Holding (GO) PT Raised to $12 at TD Cowen
- CrowdStrike (CRWD) PT Raised to $250 at Benchmark Ahead of Q2 Results
Create E-mail Alert Related Categories
Analyst PT Change, Downgrades, Hot DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
